Risk of worsening renal function with nesiritide following cardiac surgery

American Journal of Health-System Pharmacy

Volumn 63, Issue 23, 2006, Pages 2351-2353

  Kristeller, Judith Lyn ^a   Papps, Haley ^a   Stahl, Russell F ^b  

^a WILKES UNIVERSITY   (United States)

^b P   (United States)

Author keywords

Cardiac drugs; Heart failure; Hemodynamics; Kidney failure; Nesiritide; Surgery; Toxicity

Indexed keywords

NESIRITIDE; NEUROHORMONE; VASODILATOR AGENT;

ACUTE HEART FAILURE; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DISEASE EXACERBATION; ELECTIVE SURGERY; HEMODYNAMICS; HORMONE RESPONSE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LENGTH OF STAY; MORTALITY; NEPHROTOXICITY; OPEN HEART SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL PROTECTION; RISK ASSESSMENT; SYMPTOMATOLOGY;

EID: 33845202498     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060250     Document Type: Article

References (13)

1. Mangano CM, Diamondstone LS, Ramsay JG et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med. 1998; 128:194-203.
2. Krumholz HM, Chen YT, Vaccarino V et al. Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol. 2000; 85:1110-3.
3. Van De Wal RM, Van Brussel BL, Voors AA et al. Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery. J Thorac Cardiovasc Surg. 2005; 129:330-5.
4. Loef BG, Epema AH, Smilde TD et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005; 16:195-200.
5. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002; 287:1531-40.
6. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005; 111:1487-91.
7. Riedel B. The pathophysiology and management of perioperative pulmonary hypertension with specific emphasis on the period following cardiac surgery. Int Anesthesiol Clin. 1999; 37:55-79.
8. Sezai A, Shiono M, Crime Y et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg. 2000; 69:732-8.
9. Samuels LE, Holmes EC, Lee L. Nesiritide as an adjunctive therapy in adult patients with heart failure undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg. 2004; 128:627-9.
10. Salzberg SP, Filsoufi F, Anyanwu A et al. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg. 2005; 80:502-6.
11. Wang DJ, Dowling TC, Meadows D et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation. 2004; 110:1620-5.
12. Valsson F, Ricksten SE, Hedner T et al. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med. 1996; 22:230-6.
13. Feldman DS, Ikonomidis JS, Uber WE et al. Human B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery. J Card Fail. 2004; 10:292-6.